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PMN-mediated microvascular barrier disruption,
edema formation, and organ injury.4-10 Transient
reduction of the post-CPB inflammatory response is
potentially beneficial, minimizing post-CPB organ
dysfunction.10,11
The selectin family of adhesion molecules is com-
posed of similar calcium-dependent carbohydrate-bind-
ing proteins, E-, P-, and L-selectin.12-14 The selectins
are expressed on the endothelium after activation (E-
and P-selectins) and on the platelets (P-selectin); L-
selectin is constitutively expressed on PMNs. The
selectins mediate the initial tethering and rolling of
PMNs along the vascular endothelium binding to sialyl
Lewisx ligands.15 Interruption of the mechanism of ini-
tial tethering and rolling has prevented PMN adhesion
on the microvasculature in vitro, and the use of selectin
antagonists has reduced tissue damage in direct lung
injury and ischemia/reperfusion models.16-18
Smith and colleagues2 established the canine mesen-
teric lymphatic fistula as an ideal model by which to
study microvascular barrier injury associated with CPB.
Cardiopulmonary bypass (CPB) is associated with ageneralized inflammatory response with splanch-
nic and pulmonary edema formation that is associated
with microvascular barrier injury.1-4 Recent studies
suggest that, with the initiation of CPB, interactions
between polymorphonuclear neutrophils (PMNs) and
the endothelium are the early events in the initiation of
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We sought to study the effects of blocking the PMN-
endothelial tethering on microvascular permeability
and edema formation associated with CPB. By mini-
mizing PMN adherence, using a selectin antagonist that
binds to P-, E-, and L-selectins and preventing interac-
tions with their ligands, we hypothesized there would
be less PMN infiltration into the tissue and a reduction
in microvascular permeability to protein and edema
formation.14,15 Moreover, we have chosen to study the
mesenteric microvasculature because of a growing
body of evidence that shows the postischemic gut
serves as a priming bed for circulating PMNs that pro-
voke multiorgan failure.19 Thus, in theory, a reduction
of PMN adherence in the gut could potentially alter the
post-CPB inflammatory response.
Methods
Animal preparation. All procedures were approved by the
University of Texas Animal Welfare Committee and were
consistent with the “Guide for the Care and Use of
Laboratory Animals” published by the National Institutes of
Health. Conditioned mongrel dogs of either sex (30.3 ± 0.7
kg [control animals]; 31.6 ± 0.5 kg [experimental animals])
were anesthetized with intravenous administration of thio-
pental sodium, 25 mg/kg (Abbott Laboratories, North
Chicago, Ill), intubated, and mechanically ventilated at a tidal
volume of 15 mL/kg body weight, positive end-expiratory
pressure of 5 cm H2O, respiratory rate of 10 breaths/min with
100% oxygen with the use of a volume-cycled respirator
(model 900C; Siemens-Elema AB, Solna, Sweden).
Anesthesia was maintained with intravenous infusion of 1%
thiopental sodium in Ringer solution.
Fluid-filled catheters were placed into the left femoral
artery and vein and connected to pressure transducers for
mean arterial pressure monitoring, arterial blood sampling,
and fluid administration, respectively. A 7F thermodilution
catheter (Swan-Ganz; Baxter-Edwards Critical Care, Irvine,
Calif) was inserted into the pulmonary artery through the left
jugular vein for central venous pressure, pulmonary artery
pressure, and cardiac output determination. The right femoral
artery was exposed for subsequent CPB cannulation. The
pressure monitoring catheters were connected to pressure
transducers (Isotec; Healthdyne Cardiovascular Inc, Irvine,
Calif), and data were recorded on an 8-channel chart recorder
(Grass Instrument Co, Quincy, Mass). We determined cardiac
output in duplicate with the use of a cardiac output computer
connected to a Swan-Ganz thermodilution pulmonary artery
catheter. A 10 mL dose of ice cold Ringer solution was used
as the injectate. A urinary drainage catheter was placed in the
bladder at the time of laparotomy, and urine output was mea-
sured every 30 minutes. Arterial blood gas measurements
were made with the use of an automated blood gas analyzer
(IL-BGE; Instrumentation Laboratories, Lexington, Mass).
The experimental preparation is a modification of the
Kubes/Granger model.20 To obtain the measurements of lym-
phatic flow and lymph protein concentration (CL), a midline
laparotomy was performed, and a mesenteric lymphatic was
cannulated with 0.025-inch inner diameter tubing (Silastic;
Dow Corning, Midland, Mich). This cannula was attached to
a micropipette, which was fixed in a horizontal position, level
with the lymphatic vessel, to prevent hydrostatic pressure
from affecting lymphatic flow rates. Lymph flow (QL) was
measured by timing the lymph fluid meniscus movement in
the micropipette with a stopwatch. A variable pressure
occluder was placed circumferentially around the superior
mesenteric vein and was used to elevate mesenteric venous
pressure to achieve the interstitial protein “washdown.” A dis-
tal mesenteric venous tributary was then cannulated with
0.025-inch inner diameter tubing and attached to a pressure
transducer that was interfaced with a Grass physiologic
recorder (Grass Model 7D Polygraph; Grass Instrument Co,
Quincy, Mass). This was used to estimate capillary pressure
according to the method of Granger and colleagues.21
Capillary pressure was measured by the venous occlusion
technique, which results in a rapid rise in the venous pressure
to capillary pressure, after which the increase in pressure is
more gradual. This was graphically measured by increasing
the chart speed on the chart recorder; the inflection point rep-
resents capillary pressure. CL and plasma protein concentra-
tion (CP) were determined with a refractometer (American
Optical, Buffalo, NY). Colloid oncotic pressure was calculat-
ed from protein concentrations with the equation of Navar
and Navar.22 The reflection coefficient is a surface area inde-
pendent coefficient that represents the ability of the mem-
brane to selectively limit the passage of macromolecules. A
reflection coefficient of 1 represents an impermeable mem-
brane, and a reflection coefficient of 0 represents no barrier
function. Transvascular protein clearance was calculated as
QL × CL/CP and used in conjunction with reflection coeffi-
cient as a marker of microvascular permeability to protein.
The description of these variables and the rationale for their
use is described further in the appendix.
Intestinal water content determination. For intestinal
water content determination, we modified a gravimetric tech-
nique, originally developed for cerebral tissue.23 Intestinal
water content was determined by specific density measure-
ment of small ileal tissue samples with a linear density gradi-
ent. If the specific density of an ileal tissue sample is known,
the percent gram water per gram tissue can be calculated.
Experimental drug. TBC 1269 is a selectin antagonist that
acts by binding to the selectin adhesion molecules, prevent-
ing interactions with their cognate ligands.14,15 It is a dimeric
synthetic mannosylated-biphenyl class compound. It has a
half-life of approximately 2 hours in rats, and doses of 25
mg/kg have minimized hepatic ischemia/reperfusion injury
by reducing PMN infiltration. The compound operates by
inhibiting PMN recruitment to the site of inflammation by
blocking the initial rolling phase of PMN recruitment. The
drug was given 10 minutes before the initiation of CPB in a
dose of 25 mg/kg, and a continuous infusion of 5 mg/kg was
subsequently administered for the duration of the experimen-
tal period. The control group received the same volume of
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0.9% saline solution vehicle. This dose was chosen because
of its efficacy in preventing myocardial ischemia/reperfusion
injury. We have performed studies that demonstrate a peak
serum level of 171 ± 10 µg/mL in 5 dogs. These studies con-
firmed adequate drug levels with this dosing regimen.
CPB techniques. After preparation, heparin (300 IU/kg)
was given intravenously for systemic anticoagulation.
Additional doses of heparin, 75 IU/kg, were administered
every 60 minutes throughout the experiment. We introduced
a 16F arterial perfusion cannula into the prepared right
femoral artery. A 2-stage (34F/38F) venous cannula (model
TAC2; DLP Inc, Grand Rapids, Mich) was inserted into the
right atrium and inferior vena cava through a median ster-
notomy. No cardioplegia, left ventricular vent, or aortic
crossclamp was used. We primed the extracorporeal circuit
and the membrane oxygenator (Cobe HVRF-3700; Cobe
Cardiovascular, Arvada, Colo) with 800 mL of Ringer solu-
tion and 1000 IU of heparin. A rectal temperature probe was
placed, and the body temperature was maintained at 37°C
during extracorporeal circulation with the use of a heat
exchanger (Sarns heater-cooler; Sarns/3M, Ann Arbor,
Mich). We maintained CPB flow between 70 and 90 mL ·
kg–1 · min–1 and mean systemic perfusion pressure between
60 and 80 mm Hg. Lactated Ringer solution was added to the
reservoir to maintain a constant level of 100 mL.
Experimental protocol. Animals were randomly assigned
to either the control or experimental groups. Experimental
animals (n = 6 animals) received 25 mg/kg pretreatment with
TBC 1269 followed by a constant infusion of 5 mg/kg there-
after. Control animals (n = 6 animals) received the same vol-
ume of only vehicle. After instrumentation, we recorded
baseline measurements of cardiac output, mean arterial pres-
sure, pulmonary artery pressure, and right atrial pressure
(central venous pressure). Lymph flow rate, lymph and plas-
ma protein determinations, and capillary pressure measure-
ments were made. Once baseline measurements were com-
pleted, mesenteric venous pressure was elevated in 1 step to
30 ± 1 mm Hg in control animals and to 30 ± 1 mm Hg in
experimental animals to obtain a minimum CL/CP. Once a
steady state was achieved as evidenced by 2 similar CL mea-
surements 15 minutes apart, CPB was initiated. Previous
experiments of 3 to 4 hours failed to demonstrate further
“washdown” with reduction in CL. All other variables were
measured at 30-minute intervals for 2 hours of CPB. At the
conclusion of the CPB period, the CPB flow was reduced,
and the dog was weaned and separated from CPB. Ileal tissue
samples were taken at baseline and steady-state every 30
minutes for gravimetric tissue water determinations.
Assay of tissue myeloperoxidase. Myeloperoxidase tissue
levels were analyzed as an index of neutrophil infiltration in
the tissue. The presence of myeloperoxidase, an enzyme spe-
cific for neutrophils, was determined in ileal tissue by the
method described by Bradley and colleagues24 and modified
by Mullane and colleagues.25 To determine myeloperoxidase
activity, we subjected ileal tissue samples to a spectrophoto-
metric assay. In brief, samples from the ileum were snap
frozen in liquid nitrogen and stored at –70°C until processed.
Samples were pulverized, then homogenized (10% wt/vol)
with a Polytron homogenizer (model PT2000; Brinkman
Instruments, Inc, Westbury, NY) in 50 mmol phosphate
buffer solution (pH = 6.0) containing 0.5% hexade-
cyltrimethyl ammonium bromide (Sigma Chemical Co, St
Louis, Mo) for 90 seconds. Homogenates were centrifuged at
12,500g for 45 minutes (4°C). The supernatant was added to
0.166 mg/mL ο-dianisidine dihydrochloride (Sigma) and
0.0005% hydrogen peroxide in 50 nmol/L phosphate buffer
(pH = 6.0). The change in absorbance was measured spec-
trophotometrically at 460 nm (Beckman DU 640; Beckman
Instruments, Inc, Fullerton, Calif) every 5 seconds for 2 min-
utes. Results were expressed as units of myeloperoxidase per
100 mg tissue (wet weight), where 1 unit of myeloperoxidase
activity was defined as the quantity of enzyme degrading 1
µmol/L peroxide per minute at 25°C. The average for the
duplicates was used for analysis.
Statistical analysis. All data presented are mean ± SE. We
examined the time courses of each measured parameter using
analysis of variance (ANOVA) for repeated measures and the
Fisher least significant difference test. Time point compar-
isons were made using the unpaired Student t test.
Results
Lymph flow is shown in Fig 1. There is no significant
difference between control and experimental groups.
Although control results demonstrate a significant
increase in QL (P = .03 at 30 minutes of CPB; ANOVA
and the Fisher least significant difference test) after
CPB was initiated, the absolute flow rates are not dif-
ferent between groups. As demonstrated graphically,
this is due to the higher QL at washdown in experimen-
tal animals compared with control animals. As shown
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Fig 1. QL increases with the increase in mesenteric venous
pressure. There is no statistical difference in QL between
groups after the initiation of CPB. *Statistical significance
with respect to wash down in control group (P = .02 at 30
minutes of CPB compared with wash down).
in Fig 2, there is no statistically significant difference in
the reflection coefficient between control and experi-
mental animals. Compared with washdown, reflection
coefficient is lower with the initiation of CPB in both
groups, but this does not reach statistical significance
(P = .07; ANOVA and the Fisher least significant dif-
ference test). Transvascular protein clearance (Fig 3)
significantly increases in both control and experimental
animals after CPB is initiated, but there are no signifi-
cant differences between groups. Ileal tissue water (Fig
4) increases in both control and experimental groups
after the initiation of CPB. At the conclusion of CPB,
ileal tissue water is almost identical in experimental
and control animals. Ileal tissue myeloperoxidase is
statistically lower (P < .05) in experimental (0.36 ±
0.04 U/100 mg tissue) compared with control (0.97 ±
0.09 U/100 mg tissue) animals 30 minutes after the
conclusion of CPB.
Discussion
The purpose of this study was to determine whether
the blockade of the initial steps of PMN adherence
could affect the intestinal microvascular permeability
and edema formation associated with the initiation of
CPB. Our study shows that selectin blockade before
CPB reduces PMN accumulation in the ileum but does
not significantly affect microvascular permeability to
protein or ileal edema formation.
Although we found that selectin blockade decreased
CPB-induced ileal tissue PMN infiltration, selectin
blockade did not affect protein permeability. Although
we did not demonstrate a reduction in permeability to
total protein (decreases in transvascular protein clear-
ance), the possibility remains that a protein fractionation
technique could detect more subtle microvascular per-
meability changes. The reduction in leukocyte seques-
tration without alterations in microvascular permeability
initially seems contradictory but is quite similar to pre-
vious data reported from lung tissue in a canine model of
CPB. Dreyer and colleagues4 demonstrated a significant
reduction in pulmonary leukocyte sequestration with the
use of a monoclonal antibody against CD18 (R15.7).
However, similar to our ileal data, there was no signifi-
cant reduction in lung tissue water. These data are con-
sistent with clinical studies that show an increase in pul-
monary leukocyte sequestration, with only modest
deterioration in lung function with CPB.
An alternative explanation of our data is that the ini-
tial events of increased microvascular permeability are
not PMN mediated; thus altering PMN adherence
would not be expected to decrease the permeability
changes. Indeed, numerous other events associated
with blood–foreign surface interactions can increase
microvascular permeability. These include mast cell
degranulation, histamine release, and complement acti-
vation (independent of PMN-mediated injury).
If the PMN is the putative mediator of the tissue
injury associated with CPB, then these data seem
somewhat contradictory. Specifically, there are fewer
PMNs within the tissue in the experimental group, but
there is no demonstrable decrease in tissue injury. We
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Fig 2. Reflection coefficient (Sigma) decreases with the initi-
ation of CPB, indicating a modest increase in the microvas-
cular permeability to protein. There is no statistically signifi-
cant difference between groups.
Fig 3. Transvascular protein clearance increases with the ini-
tiation of CPB, indicating an increase in microvascular per-
meability to protein. Although transvascular protein clear-
ance increases from wash down (P = .01, comparing wash
down with 30-minute CPB), there is no statistical difference
between groups. *Statistical significance within groups, com-
paring individual time points with wash down.
hypothesize that our data represent the initial up-regu-
lation of adhesion molecules in the microcirculation
and on the PMNs and that this results in the accumula-
tion of PMNs within the tissue. Of critical importance,
the only inflammatory stimulus in our model is the ini-
tiation of CPB. In that regard, this mimics the clinical
scenario of routine procedures requiring CPB. In con-
trast, models that use successive inflammatory stimuli
(eg, shock-endotoxin, burn-endotoxin) have shown
exaggerated tissue injury when compared with singular
inflammatory stimuli. Moreover, as described by
numerous authors, these PMNs are probably “primed”
by the initial inflammatory stimulus to increase oxy-
gen-derived free radicals and proteases, which are sub-
sequently released with further stimulation.27 With
complicated or prolonged CPB, gut epithelial barrier
dysfunction has been demonstrated along with indirect
evidence of bacterial/endotoxin translocation.28 It has
been hypothesized that this is responsible for PMN
activation associated with CPB. However, without fur-
ther stimulation, there is no substantial increase in
PMN-mediated tissue injury. We have demonstrated
this phenomenon previously using an ovine model of
direct lung injury followed by extracorporeal mem-
brane oxygenation as cardiopulmonary support. We
showed an augmented pulmonary leukocyte sequestra-
tion and exacerbated lung injury after the initiation of
extracorporeal membrane oxygenation.27 These data
support the hypothesis that a second inflammatory
stimulus to a “primed” PMN results in an augmented
inflammatory response and organ injury.
The systemic inflammatory response associated
with CPB is related, in part, to PMN activation. PMN
activation associated with CPB is due to several fac-
tors: blood–foreign surface interactions, global
ischemia-reperfusion, and altered blood flow patterns.
The recognition of the critical role of the PMN in the
pathophysiologic response to CPB has stimulated
efforts to minimize the PMN-mediated tissue injury
associated with CPB. PMNs adhere to the activated
venular endothelium in response to inflammatory
stimuli through specific PMN-endothelial interac-
tions.15 Once PMNs are recruited into tissue, the acti-
vated PMN releases oxygen-derived free radicals and
enzymes, such as elastase. Specific efforts have
focused on reducing PMN adherence to the activated
venular endothelium to minimize the pulmonary
microvascular injury and subsequent pulmonary
edema formation associated with CPB. In the past,
clinicians empirically used methylprednisolone to
reduce the inflammatory symptoms seen after CPB.
Clinical studies demonstrated that methylpred-
nisolone decreased the systemic inflammatory
response not only by reducing tumor necrosis factor α
release but also by reducing CD11b up-regulation on
the PMN surface.11 More recently, specific
CD11b/CD18 adhesion monoclonal antibodies and
agents to prevent CD11b/CD18 adhesion molecule
up-regulation have been used experimentally to
reduce the PMN-mediated lung injury associated with
CPB.4 Some concern has been raised about the poten-
tial use of these types of agents in clinical practice.
Immunosuppression and impaired wound healing
associated with corticosteroid use have prevented a
widespread acceptance of this approach to reduce the
systemic inflammatory response associated with
CPB. Although monoclonal antibodies are more spe-
cific in their reduction of the inflammatory response,
they expose patients to foreign proteins and possible
serum sickness. For these reasons, there has been
interest in a selective approach to reducing PMN-
mediated tissue injury that does not require a global
down-regulation of the inflammatory response or the
exposure to foreign proteins.
The selectins mediate the initial rolling and tethering
of PMNs to the activated venular endothelium before
firm adhesion and transendothelial migration occur.
There is some overlap in their function with ligands on
both the PMN and endothelium such that the blockade
of a single selectin does not totally prevent the initial
PMN rolling. Likewise, most global inflammatory
stimuli that result in increased circulating proinflam-
matory cytokines up-regulate all 3 selectins. In vivo
approaches to block selectin–dependent inflammatory
responses have been developed. These techniques con-
sist of infusing selectin-reactive sulfated oligosaccha-
rides that functionally bind to the up-regulated
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Fig 4. Tissue water (ileum) as measured by microgravimet-
rics. There is no statistically significant difference between
groups.
selectins on the vascular endothelium and PMN.12
These approaches have proved effective in reducing
PMN-mediated lung injury because of smoke inhala-
tion and cobra venom factor.12,16,18 These molecules are
potentially useful because of their short half-life,
focused effects, and lack of foreign protein exposure.
These effects are the rationale for the use of a selectin
antagonist with CPB.
In summary, we studied the effects of a selectin
antagonist, TBC 1269, on microvascular permeability
and leukocyte sequestration associated with CPB. CPB
increased mesenteric microvascular permeability as
measured by increased transvascular protein clearance,
but this was not reduced by TBC 1269. Post–CPB ileal
leukocyte sequestration was decreased by TBC 1269.
These data must be considered when anti-inflammato-
ry strategies for CPB are being developed.
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Appendix
Starling equation.  Transcapillary fluid filtration rate (JV)
is determined by the Starling forces as calculated from the
equation:
QL = JV = Kf([PC – Pi] – σ[πc – πi]) (1)
where QL = lymph flow, Kf = capillary filtration coefficient,
PC = capillary pressure, Pi = interstitial pressure, σ = reflec-
tion coefficient, π
c
= plasma oncotic pressure, and πi = inter-
stitial oncotic pressure.
Reflection coefficient, σ, was calculated by simultaneous-
ly measuring CL and CP, respectively, after interstitial protein
“washdown” was induced by elevated mesenteric venous
pressure. When CL/CP reached filtration independence:
σ = 1 – CL/CP (2)
The Navar equation is used for the conversion of protein
concentrations into oncotic pressures. It is shown as equation
(3), where C is the protein concentration and π is oncotic
pressure.
π = 1.4C + 0.22C2 + 0.005C3 (3)
Intestinal tissue water measurements. For preparation of
the density gradient, we used 2 mixtures of kerosene (specif-
ic gravity, 0.773) and bromobenzene (specific gravity, 1.484).
The specific gravities of these mixtures were adjusted to
0.983 and 1.073, respectively, and the density column was
generated with a gradient former (model GC-0971; Bethesda
Research Laboratories, Bethesda, Md). We then calibrated
the gradient with various K2SO4 solutions with known spe-
cific gravities of 1.086, 1.079, 1.072, 1.067, 1.044, 1.035,
1.031, and 1.027. We carefully placed 10-µL drops of the
K2SO4 solutions in the gradient and recorded the equilibra-
tion depth after 1 minute. We then plotted equilibration depth
versus specific gravity and confirmed the linearity of the gra-
dient by linear least square regression analysis. The mean
correlation coefficient was 0.987 ± 0.0003 (n = 12).
To determine the specific gravity of ileum, we sharply
excised full-thickness ileal tissue samples (6-8 mm3). These
samples were gently placed into the density gradient, and the
equilibration depth was recorded after 1 minute. The gram
water per gram ileum or ileal water content (IWC, %) was
calculated with the following equation:
IWC = (1 - [(SGileal – 1)/(1 – 1/SGdry) · SGileal]) · 100% (4)
where SGileal and SGdry are the specific gravities of the ileal
tissue sample and of dry ileum, respectively. At the end of the
experiment, we killed the dog with intravenous thiopental
sodium overdose and saturated potassium chloride. The
bowel was then weighed, after which a sample was stored in
an oven and dried to a constant weight at 60°C. We calculat-
ed SGdry with the following equation:
SGdry = 1/(1 – [SGileal – 1] · W/[D · SGileal)]) (5)
where W and D are wet and dry weights of ileum, respec-
tively. We assumed that SGdry did not change over the exper-
imental period. All ileal tissue water content measurements
were performed in triplicate.
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